Results 201 to 210 of about 210,353 (388)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Clinical pharmacology and therapy, 2017
Julie A. Johnson, K. Caudle, L. Gong, Michelle Whirl‐Carrillo, C. Stein, S. Scott, M. M. Lee, B. Gage, S. Kimmel, M. Perera, Jeffrey L. Anderson, M. Pirmohamed, T. Klein, N. Limdi, L. Cavallari, M. Wadelius   +15 more
semanticscholar   +1 more source

Medicinal cannabis: is current use clinically justified?

Internal Medicine Journal, EarlyView.
Abstract Cannabis products are increasingly perceived and advertised as natural and safe treatments for a variety of conditions, including chronic non‐cancer pain (CNCP). The number of prescriptions for medicinal cannabis (MC) currently averages >80 000 per month for >1 million Australians. Although over 800 different cannabis products are available to
Russ J. Scott, Ian A. Scott
wiley   +1 more source

Collaborative Study of a Semiautomated Method for the Analysis of Acenocoumarol, Phenprocoumon, and Potassium Warfarin Tablets [PDF]

, 1975
Richard E. Kolinski
openalex   +1 more source

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

New England Journal of Medicine, 2013
H. Büller, H. Décousus, M. Grosso, M. Mercuri, S. Middeldorp, M. Prins, G. Raskob, S. Schellong, L. Schwocho, A. Segers, M. Shi, P. Verhamme, P. Wells   +12 more
semanticscholar   +1 more source

Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors

Internal Medicine Journal, EarlyView.
ABSTRACT Background Bruton's tyrosine kinase inhibitors (BTKi) reduce mortality and morbidity in chronic lymphocytic leukaemia (CLL) but have an association with cardiotoxicities, including hypertension, atrial fibrillation (AF), ventricular arrhythmias (VA) and bleeding.
Mary Ann Anderson, Farrukh T. Awan, Leanne Berkahn, Kyle Crassini, Hui‐Peng Lee, Paula Marlton, Stephen P. Mulligan, Mark Nolan, Constantine Tam, Aaron L. Sverdlov   +9 more
wiley   +1 more source

Surreptitious Warfarin Ingestion in three Nurses with Co-Existing Bleeding Disorders [PDF]

, 1977
Ormille A. Hayne, Л. А. Шерман, Lamont W. Gaston, Elise Fraser   +3 more
openalex   +1 more source

Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT This state‐of‐the‐art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated ...
Sanjeev Saksena, April Slee, Ranghadham Nagarakanti, Atul Prakash   +3 more
wiley   +1 more source

A. c. polarographic determination of Warfarin

, 1969
Tadayuki OMURA, Shukuro MORISHITA, Chie Aikawa, Yoshihiko Ueda   +3 more
openalex   +2 more sources

Stereoselective interaction between the R enantiomer of warfarin and cimetidine. [PDF]

, 1986
IA Choonara, S. Cholerton, BP Haynes, AM Breckenridge, BK Park   +4 more
openalex   +1 more source

INTERACTIONS WITH WARFARIN [PDF]

British Journal of Clinical Pharmacology, 1974
openaire   +3 more sources